Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Aromatase ELISA Kit (AC3517)
Cat.#: ASET-2106
Specifications
Description Human Aromatase ELISA Kit allows for the in vitro quantitative determination of human Aromatase concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1525 Human beta Catenin ELISA Kit (AC2936) Quantitative inquiry ASET-1135 Human KCNK17 ELISA Kit (AC2546) Quantitative inquiry ASET-2193 Human Robo4 ELISA Kit (AC3604) Quantitative inquiry ASET-1984 Mouse PGP9.5 ELISA Kit (AC3395) Quantitative inquiry ASET-2061 Rat NF-kB p65 ELISA Kit (AC3472) Quantitative inquiry ASET-1770 Rat AVPR1B ELISA Kit (AC3181) Quantitative inquiry ASET-1295 Human NPFF2 Receptor ELISA Kit (AC2706) Quantitative inquiry ASET-2165 Human PZP ELISA Kit (AC3576) Quantitative inquiry ASET-1740 Rabbit Myelin Basic Protein ELISA Kit (AC3151) Quantitative inquiry ASET-1191 Mouse NMDAR2B ELISA Kit (AC2602) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket